Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.

BACKGROUND: In epidemiological studies, within-person variability in plasma total homocysteine (tHcy) measurements may dilute the association of 'usual' levels of tHcy with risk of cardiovascular disease, referred to as 'regression dilution'. The aim of this report was to estimat...

Full description

Bibliographic Details
Main Authors:	Clarke, R, Lewington, S, Donald, A, Johnston, C, Refsum, H, Stratton, I, Jacques, P, Breteler, M, Holman, R
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Homocysteine, renal function, and risk of cardiovascular disease.
by: Clarke, R, et al.
Published: (2003)

Homocysteine and risk of cardiovascular disease and venous thrombosis
by: Clarke, R, et al.
Published: (2003)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
by: Den Heijer, M, et al.
Published: (2005)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
by: Clarke, R, et al.
Published: (2007)

Homocysteine, B vitamins, and cardiovascular disease.
by: Refsum, H, et al.
Published: (2006)

Homocysteine, B vitamins, and cardiovascular disease
by: Refsum, H, et al.
Published: (2006)

Homocysteine and coronary heart disease.
by: Clarke, R, et al.
Published: (2002)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
by: Clarke, R, et al.
Published: (2001)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
by: Clarke, R
Published: (2011)

Homocysteine and prediction of coronary heart disease and stroke
by: Clarke, R, et al.
Published: (2003)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
by: Clarke, R, et al.
Published: (2011)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
by: Clarke, R, et al.
Published: (2011)

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.
by: Clarke, R, et al.
Published: (2002)

Homocysteine and cardiovascular disease. Overview.
by: Clarke, R
Published: (1998)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
by: Clarke, R, et al.
Published: (2005)

Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated
by: Serafino Fazio, et al.
Published: (2024-03-01)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
by: Price, H, et al.
Published: (2007)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
by: Danesh, J, et al.
Published: (1998)

Underestimation of BP risk association due to regression dilution in long-term follow-up of prospective studies
by: Lewington, S, et al.
Published: (1998)

Underestimation of the importance of isolated systolic hypertension in older people
by: Clarke, R, et al.
Published: (2009)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
by: Clarke, R
Published: (2009)

Unlinked data sources underestimate risk of cardiovascular disease.
by: Stevens, R, et al.
Published: (2013)

Unlinked data sources underestimate risk of cardiovascular disease.
by: Stevens, R, et al.
Published: (2013)

Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.
by: Clarke, R, et al.
Published: (1999)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
by: Stevens, R, et al.
Published: (2005)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
by: Clarke, R, et al.
Published: (2000)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
by: Clarke, R
Published: (2002)

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.
by: Prins, N, et al.
Published: (2002)

Homocysteine and brain atrophy on MRI of non-demented elderly.
by: den Heijer, T, et al.
Published: (2003)

Homocysteine, B vitamins, and the risk of dementia.
by: Clarke, R
Published: (2007)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
by: Clarke, R, et al.
Published: (2007)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
by: Jan Filipovský
Published: (2007-08-01)

Homocysteine, B vitamins, and cognitive impairment
by: Smith, A, et al.
Published: (2016)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
by: Ueland, P, et al.
Published: (2007)

Facts and recommendations about total homocysteine determinations: an expert opinion
by: Refsum, H, et al.
Published: (2004)

The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis
by: Jerzy Głuszek, et al.
Published: (2020-10-01)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
by: Lewington, S, et al.
Published: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
by: Lewington, S, et al.
Published: (2005)

Homocysteine and cerebral white matter lesions: The Rotterdam Scan Study
by: van Dijk, E, et al.
Published: (2001)